Rubius Therapeutics Inc (RUBY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select FieldsSymbol | RUBY | MBRX | PPBT | ||
Company | Rubius Therapeutics Inc | Moleculin Biotech CS | Purple Biotech Ltd ADR | ||
Price Information | |||||
Exchange | OTC US | NASDAQ | NASDAQ | ||
Open | 0.0555 | 1.8000 | 3.40 | ||
High | 0.0570 | 1.8900 | 3.49 | ||
Low | 0.0550 | 1.6700 | 3.31 | ||
Last | 0.0570 | 1.6700 | 3.42 | ||
Change | +0.0015 | -0.1400 | -0.03 | ||
% Change | +2.70% | -7.73% | -0.87% | ||
Volume | 755,800 | 59,200 | 112,000 | ||
20-Day Average Volume | 190,760 | 49,175 | 2,753,400 | ||
Previous Close | 0.0555 | 1.8100 | 3.45 | ||
Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
Has Options | No | No | Yes | ||
Technicals | |||||
20-Day Moving Average | 0.0272 | 2.4050 | 4.04 | ||
20-Day Raw Stochastic | 100.00% | 0.00% | 11.88% | ||
20-Day Relative Strength | 84.64% | 34.83% | 46.80% | ||
Weighted Alpha | -42.49 | -78.65 | -88.45 | ||
Today's Opinion | 88% Buy | 88% Sell | 72% Sell | ||
Previous Opinion | 88% Buy | 88% Sell | 72% Sell | ||
Last Month's Opinion | 24% Sell | 40% Sell | 100% Sell | ||
Performance | |||||
5-Days | |||||
%Chg | +185.00% since 12/21/23 | -28.02% since 12/13/24 | -10.70% since 12/13/24 | ||
Low | 0.0200 on 12/22/23 | 1.6700 on 12/20/24 | 3.31 on 12/20/24 | ||
High | 0.0570 on 12/29/23 | 2.2900 on 12/16/24 | 4.22 on 12/16/24 | ||
1-Month | |||||
%Chg | +200.00% since 11/29/23 | -37.45% since 11/20/24 | +38.46% since 11/20/24 | ||
Low | 0.0181 on 12/01/23 | 1.6700 on 12/20/24 | 2.00 on 11/22/24 | ||
High | 0.0570 on 12/29/23 | 3.1000 on 12/11/24 | 13.95 on 12/02/24 | ||
3-Month | |||||
%Chg | +251.85% since 09/29/23 | -29.54% since 09/20/24 | -50.36% since 09/20/24 | ||
Low | 0.0162 on 10/09/23 | 1.6700 on 12/20/24 | 2.00 on 11/22/24 | ||
High | 0.0570 on 12/29/23 | 3.3300 on 11/14/24 | 13.95 on 12/02/24 | ||
6-Month | |||||
%Chg | +216.67% since 06/29/23 | -55.82% since 06/20/24 | -64.90% since 06/20/24 | ||
Low | 0.0032 on 09/25/23 | 1.6700 on 12/20/24 | 2.00 on 11/22/24 | ||
High | 0.1150 on 09/11/23 | 4.7070 on 07/18/24 | 13.95 on 12/02/24 | ||
Key Statistics | |||||
Market Capitalization, $K | 5,158 | 5,329 | 4,550 | ||
Shares Outstanding, K | 90,483 | 3,191 | 1,331 | ||
Annual Sales | 0 | 0 | 0 | ||
Annual Net Income | -179,670,000 | -29,770,000 | -19,880,000 | ||
Last Quarter Sales | 0 | 0 | 0 | ||
Last Quarter Net Income | -20,140,000 | -10,590,000 | -6,830,000 | ||
60-Month Beta | 2.20 | 1.87 | 1.12 | ||
Per-Share Information | |||||
Most Recent Earnings | N/A | -2.09 on 11/08/24 | -1.37 on 11/15/24 | ||
Latest Earnings Date | 01/03/24 | 11/08/24 | 11/19/24 | ||
Most Recent Dividend | N/A | N/A | N/A | ||
Next Ex-Dividends Date | N/A | N/A | N/A | ||
Ratios | |||||
Price/Earnings ttm | 0.00 | 0.00 | 0.00 |